Use of a combination of cyclosporine and pegylated interferon for treating hepatitis C (HCV)

Details for Australian Patent Application No. 2005261868 (hide)

Owner Novartis AG

Inventors Asakawa, Kazuo; Vachon, Guylaine; Cornu-Artis, Catherine; Mertes, Reinhild Elisabeth; Yoshiba, Shinsyou; Uryuhara, Yoko

Agent Davies Collison Cave

Pub. Number AU-B-2005261868

PCT Pub. Number WO2006/005610

Priority 04016583.9 14.07.04 EP

Filing date 13 July 2005

Wipo publication date 19 January 2006

Acceptance publication date 15 January 2009

International Classifications

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61K 31/7052 (2006.01)

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/005610 Priority application(s): WO2006/005610

15 January 2009 Application Accepted

  Published as AU-B-2005261868

14 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261869-Glucocorticoid 16alpha, 17.alpha.-isoxazolidines as antiinflammatory agents

2005261867-Substituted oxindol derivatives and medicaments containing the same